Nalaganje...

A chance to cut (the genome) is a chance to cure

In this issue of Blood, Antoniani et al identify an innovative genome editing approach to induce fetal hemoglobin (HbF), which may eventually lead to therapeutic strategies for ameliorating or curing sickle-cell disease (SCD) and β-thalassemia.(1)

Shranjeno v:
Bibliografske podrobnosti
izdano v:Blood
Main Authors: Montbleau, Kara E., Sankaran, Vijay G.
Format: Artigo
Jezik:Inglês
Izdano: American Society of Hematology 2018
Teme:
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC5921966/
https://ncbi.nlm.nih.gov/pubmed/29699995
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2018-03-839787
Oznake: Označite
Brez oznak, prvi označite!